MAPK8 and early-onset autosomal dominant Alzheimer disease: For example, VB-037, a quinoline derivative, restrained ROS level by controlling the HSP27 and P38/JNK signaling pathways to improve neuron damage and neuroinflammation, providing a promising direction for exploring therapeutic candidates for Alzheimer’s disease (Chiu et al., 2019).